Примери за използване на Orencia на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
How does Orencia work?
Other medicines and ORENCIA.
What is Orencia used for?
Medication name Orencia.
Orencia(which contains abatacept).
What is Orencia?
Why is Orencia authorised in the EU?
If you forget to receive ORENCIA.
Zessly and Orencia should not be used together.
Children between 2 and 6 years should only use Orencia pre-filled syringes.
Orencia contains the active substance abatacept.
When injected under the skin, Orencia is given once a week.
ORENCIA has not been studied in these patient populations.
Four main studies involving a total of 1,733 adults found Orencia effective in rheumatoid arthritis.
ORENCIA, in combination with methotrexate, is indicated for.
In rheumatoid arthritis,if the patient is receiving Orencia for the first time, the first dose can be given by infusion.
Orencia was also shown to reduce symptoms of psoriatic arthritis.
When given by infusion into a vein, Orencia is given every 2 weeks for the first 3 doses, and then every 4 weeks.
Orencia(abatacept)- Conditions or restrictions regarding supply and use- L04AA24.
The active substance in Orencia, abatacept, is a protein that suppresses the activation of T cells.
ORENCIA is used to treat psoriatic arthritis alone or in combination with methotrexate.
The Agency also concluded that Orencia could be a valuable option in the treatment of polyarticular juvenile idiopathic arthritis.
If Orencia has not worked within 6 months, the doctor should consider if treatment should continue.
The second study found a similar effect of Orencia on symptoms of rheumatoid arthritis, as well as improved physical function and a reduced rate of joint damage after a year of treatment.
Orencia is a medicine that is often used in combination with methotrexate(a medicine that acts on the immune system) to treat the following diseases.
In polyarticular juvenile idiopathic arthritis, Orencia infusion was found effective in one main study involving patients aged between 6 and 17 years whose previous treatment had not worked.
Orencia is available as a powder that is made up into a solution for infusion(drip) into a vein and as a solution for injection under the skin in pre-filled syringes and pre-filled pens.
The European Medicines Agency concluded that Orencia had a modest anti-inflammatory effect in rheumatoid arthritis and, in combination with methotrexate, it reduced the worsening of joint damage and improved physical function.
Adding Orencia to existing treatment led to a reduction in symptoms in 50% of the patients(129 out of 256) after 6 months, compared with 20% of the patients adding placebo(26 out of 133).
Patients taking Orencia also had a greater improvement in physical function after six months.